Industry News

Zogenix Acquires U.K.-Based Brabant Pharma
Ebola drug maker Fujifilm to buy US vaccine maker
Virbac agrees to acquire veterinary assets from Eli Lilly in the United States
Insys Receives DEA Approval to Produce Pharmaceutical Cannabidiol; Updates on Status of Its Cannabinoid Program
FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years
INFINEX Creates Bio Critical Solutions To Join The Fight Against Cancer And Ebola
FDA approves new treatment for rare form of hemophilia
Sihuan Pharm (00460) submits IND to US FDA for new drug
Genentech Garners FDA Approval of Esbriet for Idiopathic Pulmonary Fibrosis
Genentech Garners FDA Approval of Esbriet for Idiopathic Pulmonary Fibrosis
United States : Nate Brown Quoted on Cybersecurity Risks for Medical Devices
Johnson & Johnson announces major commitment to expedite ebola vaccine development
Arbor Pharmaceuticals Announces FDA Approval of Sotylize
Johnson & Johnson announces major commitment to expedite ebola vaccine development
Contract Packaging Resources, Inc. Issues a Voluntary Nationwide Recall of Assured Brand Naproxen Sodium Tablets Due to Packaging Mix-Up
CHI's Latest Report Shows Modest Improvement in FDA Medical Device Review Times
HHS Secretary announces $840 million initiative to improve patient care and lower costs
Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge Surgical Leads For The Precision Spectra Spinal Cord Stimulator (SCS) System World's First 32-contact SCS Surgical Leads Designed to Provide More Focused Pain Relief for Patients
Dignitana AB in meeting with the Food and Drug Administration (FDA)
Dignitana AB in meeting with the Food and Drug Administration (FDA)
Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge� Surgical Leads For The Precision Spectra� Spinal Cord Stimulator (SCS) System World's First 32-contact SCS Surgical Leads Designed to Provide More Focused Pain Relief for
Chinese experimental drug sent out to Ebola-hit Africa
Chinese experimental drug sent out to Ebola-hit Africa
U.S. Food and Drug Administration accepts filing of new drug application for empagliflozin/metformin fixed-dose combination
U.S. Food and Drug Administration accepts filing of new drug application for empagliflozin/metformin fixed-dose combination